Within bioprocessing there are two QC processes. One is Production QC where technicians ensure the cells are growing and their media fits within specified ranges for cell growth. The other is Product Efficacy QC, where assays are run to test the efficacy of the drug prior to distribution.

The bioavailability of insulin analogs is strongly dependent on not only the primary structure of the analog but also the formulation. Here, AUC can be leveraged as a potential tool to analyze the higher-order structure of insulin under typical formulation conditions.

Analytical ultracentrifugation excels at determining the percent of viral capsids that are intact and how many of those intact capsids carry transgenic cargo.